AOD-9604 Dosage Chart AOD-9604 is dosed at 300 mcg500 mcg daily via subcutaneous injection in educational protocols
Doses Per Vial 5mg vial: At 2.5mg/week = 2 weeks At 5mg/week = 1 week 10mg vial: At 2.5mg/week = 4 weeks At 5mg/week = 2 weeks At 7.5mg/week = 1.3 weeks At 10mg/week = 1 week 15mg vial: At 2.5mg/week = 6 weeks At 5mg/week = 3 weeks At 10mg/week = 1.5 weeks At 15mg/week = 1 week A 10mg vial covers the first month of a standard escalation at 2.5mg/week
Sandy, 52 Vyora Member Texas Arianne, 47 Vyora Member Washington Alyssa, 32 Vyora Member Vermont Amanda, 34 Vyora Member New Mexico Sandy, 52 Vyora Member Texas Arianne, 47 Vyora Member Washington Alyssa, 32 Vyora Member Vermont Amanda, 34 Vyora Member New Mexico Honest feedback from people experiencing the difference for themselves
References Gao, B
In our experience, patients with a subacute tendinopathy that has stalled at 6 to 12 weeks of physical therapy tend to notice a meaningful change in pain and range of motion within 3 to 4 weeks of starting a BPC-157 protocol
Achilles detachment in rat and stable gastric pentadecapeptide BPC 157: promoted tendon-tobone healing and opposed corticosteroid aggravation